TCL Archive Cancer Program Critic Epstein Invited To NCAB T Make Argument: “We’re Losing War In Cancer” May 1, 1992
TCL Archive Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial October 26, 2012